Four‑Dimensional Echocardiographic Evaluation of Cardiac Iron Overload in Patients with Beta-Thalassemia Major
-
Published:2023-12-18
Issue:1
Volume:24
Page:41-48
-
ISSN:1530-7905
-
Container-title:Cardiovascular Toxicology
-
language:en
-
Short-container-title:Cardiovasc Toxicol
Author:
Fedai Ahmet Burak,Karakulak Ugur Nadir,Aladag Elifcan,Sayinalp Nilgun
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Reference19 articles.
1. Borgna-Pignatti, C., Rugolotto, S., De Stefano, P., Zhao, H., Cappellini, M. D., Del Vecchio, G. C., Romeo, M. A., Forni, G. L., Gamberini, M. R., Ghilardi, R., Piga, A., & Cnaan, A. (2004). Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica, 89(10), 1187–1193. 2. Taher, A. T., & Saliba, A. N. (2017). Iron overload in thalassemia: Different organs at different rates. Hematology American Society of Hematology Education Program, 2017(1), 265–271. https://doi.org/10.1182/asheducation-2017.1.265 3. Abtahi, F., Abdi, A., Jamshidi, S., Karimi, M., Babaei-Beigi, M. A., & Attar, A. (2019). Global longitudinal strain as an Indicator of cardiac Iron overload in thalassemia patients. Cardiovascular Ultrasound, 17(1), 24. https://doi.org/10.1186/s12947-019-0174-y 4. Nadar, S. K., Daar, S., Abdelmottaleb, W. A., Shaikh, M. M., Al Mahrouqi, H., Al-Raiisi, M., Hassan, M., Al Rawahi, B., & Al Rahbi, S. (2021). Abnormal diastolic function and global longitudinal strain in patients with Thalassemia Major on long term chelation therapy. International Journal of Cardiovascular Imaging, 37(2), 643–649. https://doi.org/10.1007/s10554-020-02036-8 5. Karakulak, U. N., Aladag, E., Hekimsoy, V., Sahiner, M. L., Kaya, E. B., Ozer, N., Aksu, S., Demiroglu, H., Goker, H., Buyukasik, Y., Ozcebe, O., Sayinalp, N., & Haznedaroglu, I. C. (2021). Four-dimensional echocardiographic evaluation of left ventricular systolic functions in patients with chronic myeloid leukaemia receiving tyrosine kinase inhibitors. Cardiovascular Toxicology, 21(3), 216–223. https://doi.org/10.1007/s12012-020-09613-2
|
|